BioPharma Resources

Drugs by condition

Drugs approved for glaucoma

Brand-name prescription drugs and biologics whose FDA label lists glaucoma as an approved use. Matched on the label phrases: "glaucoma", "ocular hypertension".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

30

Still marketed, NDA or BLA

Drug classes

3

Novel drugs

8

New molecular entities and new biologics

In development

17

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for glaucoma.

  • Zolymbus (Bimatoprost) · Thea Pharma Sep 9, 2025
  • Idose Tr (Travoprost) · Glaukos Dec 13, 2023
  • Iyuzeh (Latanoprost) · Thea Pharma Dec 13, 2022
  • Omlonti (Omidenepag Isopropyl) · Ocuvex Therap NovelSep 22, 2022
  • Durysta (Bimatoprost) · Abbvie Mar 4, 2020

All approved drugs for glaucoma, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 129 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Prostaglandin Analog (9)

  • Zioptan Tafluprost · Thea Pharma · 2012
  • Xalatan Latanoprost · Upjohn · 1996
  • Zolymbus Bimatoprost · Thea Pharma · 2025
  • Idose Tr Travoprost · Glaukos · 2023
  • Iyuzeh Latanoprost · Thea Pharma · 2022
  • Durysta Bimatoprost · Abbvie · 2020
  • Rocklatan Latanoprost, Netarsudil Dimesylate · Alcon Labs INC · 2019
  • Lumigan Bimatoprost · Abbvie · 2010
  • Travatan Z Travoprost · Sandoz · 2006

Carbonic Anhydrase Inhibitor (2)

  • Azopt Brinzolamide · Sandoz · 1998
  • Simbrinza Brimonidine Tartrate, Brinzolamide · Alcon Labs INC · 2013

Class not listed in FDA's data (19)

  • Omlonti Omidenepag Isopropyl · Ocuvex Therap · 2022
  • Rhopressa Netarsudil Mesylate · Alcon Labs INC · 2017
  • Vyzulta Latanoprostene Bunod · Bausch and Lomb · 2017
  • Betoptic Betaxolol Hydrochloride · Sandoz · 1985
  • Timoptic Timolol Maleate · Bausch and Lomb INC · 1978
  • Mitosol Mitomycin · Glaukos · 2012
  • Cosopt Pf Dorzolamide Hydrochloride, Timolol Maleate · Thea Pharma · 2012
  • Isopto Carpine Pilocarpine Hydrochloride · Sandoz · 2010
  • Combigan Brimonidine Tartrate, Timolol Maleate · Abbvie · 2007
  • Qoliana Brimonidine Tartrate · Sandoz · 2006
  • Alphagan P Brimonidine Tartrate · Abbvie · 2005
  • Istalol Timolol Maleate · Bausch and Lomb · 2004
  • Alphagan P Brimonidine Tartrate · Abbvie · 2001
  • Timolol Maleate Timolol Maleate · Sandoz · 1998
  • Cosopt Dorzolamide Hydrochloride, Timolol Maleate · Thea Pharma · 1998
  • Betimol Timolol · Thea Pharma · 1995
  • Timoptic-Xe Timolol Maleate · Bausch and Lomb INC · 1993
  • Betoptic S Betaxolol Hydrochloride · Novartis · 1989
  • Timoptic In Ocudose Timolol Maleate · Bausch and Lomb INC · 1986

Drugs in development for glaucoma

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • SpyGlass Pharma, Inc. · Cataract, Glaucoma, Ocular Hypertension

  • Timolol eye drops 0.5%Phase 33 trials

    Glaukos Corporation · Glaucoma, Ocular Hypertension

  • Gen 2 Travoprost Intracameral ImplantGen 2 Travoprost Intraocular ImplantPhase 32 trials

    Glaukos Corporation · Glaucoma

  • Inactive controlQLS-111 vehiclePhase 32 trials

    Can-Fite BioPharma · Hepatocellular Carcinoma, Cirrhosis, Open-angle Glaucoma (OAG)

  • NCX 470NCX 470 0.1%Phase 32 trials

    Nicox Ophthalmics, Inc. · Open Angle Glaucoma, Ocular Hypertension

  • OPC-1085ELPhase 31 trial

    Otsuka · Open Angle Glaucoma or Ocular Hypertension

  • QLS-111Phase 23 trials

    Qlaris Bio, Inc. · Normal Tension Glaucoma (NTG), Glaucoma, Open-angle Glaucoma (OAG)

  • BL1107Phase 22 trials

    Bausch & Lomb Incorporated · Dry Eye Disease, Glaucoma

  • Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma

  • Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma

  • AGN-193408Phase 21 trial

    AbbVie · Open-angle Glaucoma, Ocular Hypertension

  • AR-17043Phase 21 trial

    Alcon Research · Open Angle Glaucoma, Ocular Hypertension

  • ASP2767Phase 21 trial

    Astellas · Glaucoma

  • GVB-2001Phase 21 trial

    IVIEW Therapeutics Inc. · Primary Open-Angle Glaucoma (POAG)

  • intraocular implant releasing timololTimoD implantPhase 21 trial

    EyeD Pharma · Glaucoma, Ocular Hypertension

  • PG043Phase 21 trial

    Alcon Research · Open Angle Glaucoma, Ocular Hypertension

  • REGN22530Phase 21 trial

    Regeneron · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)

1 discontinued brand-name drugs whose label still names it

More on glaucoma: recruiting trials · published research

Related in ophthalmology: Wet macular degeneration · Diabetic macular edema · Dry eye disease · Geographic atrophy

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.